7-MEOTA-donepezil like compounds as cholinesterase inhibitors: Synthesis, pharmacological evaluation, molecular modeling and QSAR studies
Jazyk angličtina Země Francie Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
24929293
DOI
10.1016/j.ejmech.2014.05.066
PII: S0223-5234(14)00490-5
Knihovny.cz E-zdroje
- Klíčová slova
- 7-MEOTA, AChE/BChE inhibitors, Alzheimer's disease, Molecular modeling, QSAR, Tacrine,
- MeSH
- acetylcholinesterasa metabolismus MeSH
- butyrylcholinesterasa krev metabolismus MeSH
- cholinesterasové inhibitory chemická syntéza chemie farmakologie MeSH
- donepezil MeSH
- Electrophorus MeSH
- indany chemie farmakologie MeSH
- koně MeSH
- kvantitativní vztahy mezi strukturou a aktivitou * MeSH
- lidé MeSH
- molekulární modely MeSH
- molekulární struktura MeSH
- piperidiny chemie farmakologie MeSH
- rekombinantní proteiny metabolismus MeSH
- takrin analogy a deriváty chemie farmakologie MeSH
- vztah mezi dávkou a účinkem léčiva MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- 7-methoxytacrine MeSH Prohlížeč
- acetylcholinesterasa MeSH
- butyrylcholinesterasa MeSH
- cholinesterasové inhibitory MeSH
- donepezil MeSH
- indany MeSH
- piperidiny MeSH
- rekombinantní proteiny MeSH
- takrin MeSH
A novel series of 7-methoxytacrine (7-MEOTA)-donepezil like compounds was synthesized and tested for their ability to inhibit electric eel acetylcholinesterase (EeAChE), human recombinant AChE (hAChE), equine serum butyrylcholinesterase (eqBChE) and human plasmatic BChE (hBChE). New hybrids consist of a 7-MEOTA unit, representing less toxic tacrine (THA) derivative, connected with analogues of N-benzylpiperazine moieties mimicking N-benzylpiperidine fragment from donepezil. 7-MEOTA-donepezil like compounds exerted mostly non-selective profile in inhibiting cholinesterases of different origin with IC50 ranging from micromolar to sub-micromolar concentration scale. Kinetic analysis confirmed mixed-type inhibition presuming that these inhibitors are capable to simultaneously bind peripheral anionic site (PAS) as well as catalytic anionic site (CAS) of AChE. Molecular modeling studies and QSAR studies were performed to rationalize studies from in vitro. Overall, 7-MEOTA-donepezil like derivatives can be considered as interesting candidates for Alzheimer's disease treatment.
Citace poskytuje Crossref.org
Substituted Piperazines as Novel Potential Radioprotective Agents
In vitro investigating of anticancer activity of new 7-MEOTA-tacrine heterodimers
Development of 2-Methoxyhuprine as Novel Lead for Alzheimer's Disease Therapy